Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Oxidative stress contributes to the onset of chronic diseases in various organs, including muscles. Morroniside, a type of iridoid glycoside contained in , is reported to have advantages as a natural compound that prevents various diseases. However, the question of whether this phytochemical exerts any inhibitory effect against oxidative stress in muscle cells has not been well reported. Therefore, the current study aimed to evaluate whether morroniside can protect against oxidative damage induced by hydrogen peroxide (HO) in murine C2C12 myoblasts. Our results demonstrate that morroniside pretreatment was able to inhibit cytotoxicity while suppressing HO-induced DNA damage and apoptosis. Morroniside also significantly improved the antioxidant capacity in HO-challenged C2C12 cells by blocking the production of cellular reactive oxygen species and mitochondrial superoxide and increasing glutathione production. In addition, HO-induced mitochondrial damage and endoplasmic reticulum (ER) stress were effectively attenuated by morroniside pretreatment, inhibiting cytoplasmic leakage of cytochrome c and expression of ER stress-related proteins. Furthermore, morroniside neutralized HO-mediated calcium (Ca) overload in mitochondria and mitigated the expression of calpains, cytosolic Ca-dependent proteases. Collectively, these findings demonstrate that morroniside protected against mitochondrial impairment and Ca-mediated ER stress by minimizing oxidative stress, thereby inhibiting HO-induced cytotoxicity in C2C12 myoblasts.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11063479PMC
http://dx.doi.org/10.4062/biomolther.2024.012DOI Listing

Publication Analysis

Top Keywords

c2c12 myoblasts
12
oxidative stress
12
morroniside
8
oxidative damage
8
mitochondrial damage
8
endoplasmic reticulum
8
reticulum stress
8
demonstrate morroniside
8
morroniside pretreatment
8
stress
6

Similar Publications

Unlabelled: Disuse muscle atrophy (DMA) is characterized by progressive loss of muscle mass and strength, often accompanied by inflammation and macrophage imbalance. Here, we introduce hydrogenated silicene nanosheets (H-silicene) as a novel nanotherapeutic strategy to mitigate DMA through modulating macrophage polarization. H-silicene exhibited good biocompatibility and sustained hydrogen release.

View Article and Find Full Text PDF

Introduction: Sarcopenia (Sar) is an age-related loss of muscle mass and function. Propolis, a natural product with anti-inflammatory properties, may help prevent Sar, but its active components and mechanisms remain unclear.

Methods: Network pharmacology identified intersecting targets of propolis ethanol extract (PEE) and Sar.

View Article and Find Full Text PDF

Ferroptosis has been implicated in skeletal muscle aging. Nevertheless, specific ferroptosis-related genes (FRGs) governing skeletal muscle aging remain unclear. The aim of this study was to identify ferroptosis-related marker genes associated with skeletal muscle aging, uncovering potential therapeutic targets for skeletal muscle aging.

View Article and Find Full Text PDF

Organotypic 3D tissue models require precise electrophysiological interfaces to study function and disease. Multi-electrode arrays (MEAs) are essential for recording and stimulation, yet conventional fabrication methods are costly and time-intensive. This study demonstrates aerosol jet printing (AJP) of gold nanoparticles onto flexible polyimide substrates to produce fully gold, biocompatible MEAs for rapid customization of MEAs.

View Article and Find Full Text PDF

Therapeutic potential of sulfasalazine for sarcopenia: Insights from mouse models and clinical data.

Exp Gerontol

September 2025

Mitos Biomedical Institute, Mitos Therapeutics Inc., Daejeon, Republic of Korea; Department of Pharmacology and Medical Science, College of Medicine, Chungnam National University, Daejeon, Republic of Korea. Electronic address:

Sarcopenia, a disease marked by a progressive loss of muscle mass, increases the risks of disability and metabolic disorders, and decreases quality of life. Current therapeutic options are limited. YY1 transcriptional activity is augmented through an interaction with PHF20 at its promoter region, suppressing muscle differentiation.

View Article and Find Full Text PDF